CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more …

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical …

CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and …

Pre-pandemic, egg-based vaccine combined with CSL Seqirus' proprietary adjuvant, MF59® (an additive that acts to strengthen the immune response to vaccination), to protect against …

CSL's 2024 AGM was held on Tuesday, 29 th October 2024 (AEDT). CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the …

3 天之前 · CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United …

3 天之前 · Get the latest CSL Limited (CSLLY) stock price with financials, statistics, dividends, charts and more.

HEMGENIX ®, the first FDA-approved gene therapy for adults with haemophilia B, won Best Product for Rare/Orphan Diseases at the 2023 Prix Galien USA Award. Evolving our …

CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and …

5 天之前 · As of Apr 10, 2025. Values delayed up to 15 minutes. CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious …